Loading…
Utah Medical Products, Inc. is projected to rise to $75.19 by 2027, a +11% move from its current price of $67.96. UTMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $66.76 | $67.97 | $69.20 | +0.01% |
| Jul 14 | $66.27 | $67.98 | $69.73 | +0.03% |
| Jul 15 | $65.90 | $67.99 | $70.14 | +0.04% |
| Jul 16 | $65.59 | $68.00 | $70.49 | +0.06% |
| Jul 17 | $65.33 | $68.01 | $70.80 | +0.07% |
| Jul 18 | $65.08 | $68.02 | $71.08 | +0.08% |
| Jul 19 | $64.86 | $68.03 | $71.34 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $64.86 | $68.03 | $71.34 | +0.10% |
| Week 2 | $63.66 | $68.09 | $72.83 | +0.19% |
| Week 3 | $62.76 | $68.16 | $74.02 | +0.29% |
| Week 4 | $62.03 | $68.22 | $75.04 | +0.39% |
| Week 5 | $61.40 | $68.29 | $75.96 | +0.49% |
| Week 6 | $60.83 | $68.36 | $76.81 | +0.58% |
| Week 7 | $60.33 | $68.42 | $77.61 | +0.68% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Utah Medical Products, Inc. is a healthcare company that sells medical devices for the healthcare industry in the United States, Europe, and internationally. Its offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; it also provides DISPOSA-HOOD infant respiratory hoods and DELTRAN PLUS blood pressure monitoring systems.
The company was incorporated in 1978 and is headquartered in Midvale, Utah.
This description reflects a broad portfolio of specialized medical devices serving hospital and clinical settings, with a long-standing presence in its sector evidenced by the 1978 incorporation and Utah headquarters. The focus is on devices for maternal-fetal, neonatal, and related care that support labor, delivery, and related procedures. UTMD operates across multiple regions, including the United States and Europe, delivering products to hospitals, clinics, and other care settings.
UTMD is a healthcare company with a current price of $69.44, a market cap of $221.1M, and a rank of 3723. These basics place the stock within a specific market segment and provide a snapshot of its size and positioning.
The overall price outlook is positive over the longer horizon, with year-by-year forecasts showing a path of rising averages. The 2026 average is $69.44, rising to $136.72 by 2030, $317.81 by 2040, and $659.89 by 2050, with a maximum forecast reaching $1,079.49 by 2050. ROI figures accompany the path, with 2030 at 96.9 and 2050 at 850.3, among other yearly figures, underscoring meaningful upside alongside rising sentiment.
A major floor 11.3% below — a decisive break under it would weaken the trend.
The nearest floor, 4.0% below — buyers have tended to step in here.
The nearest ceiling, 8.8% above — a clean break opens room to run.
A major ceiling 14.5% above — clearing it would confirm fresh momentum.
Key UTMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of UTMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $69.11 | Sell | $68.86 | Sell |
| MA 10 | $70.50 | Sell | $69.21 | Sell |
| MA 20 | $68.85 | Sell | $68.82 | Sell |
| MA 50 | $66.80 | Buy | $67.51 | Buy |
| MA 100 | $66.21 | Buy | $65.92 | Buy |
| MA 200 | $62.70 | Buy | $63.92 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.68 | Neutral |
| Stoch RSI (14) | 16.37 | Buy |
| CCI (20) | -29.38 | Neutral |
| Williams %R (14) | -68.61 | Info |
| MACD (12,26,9) | -0.26 | Sell |
| ROC (12) | 4.22 | Buy |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 31.39 | Neutral |
| TRIX (15) | 0.21 | Buy |
| Awesome (5,34) | 1.23 | Buy |
| Ultimate (7,14,28) | 47.64 | Neutral |
| Momentum (10) | 1.09 | Buy |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 67.56 | Buy |
| ADX (14) | 11.69 | Neutral |
| ATR (14) | 1.45 | Info |
The 30-day technical picture is bullish, with RSI14 at 70. The near-term trend is supported by a 50-day moving average of $66.04 and a 200-day moving average of $62.07.
Support is noted at $63.34 and resistance at $69.44, with the current price of $69.44 positioned at the nearer end of the range. The 30-day price range runs from $64.54 to $74.71, indicating a relatively tight band around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $56.50 | $67.96 | $86.50 | 0% | Neutral | |
| $61.58 | $75.19 | $95.99 | +11% | Neutral | |
| $72.70 | $90.44 | $118.57 | +33% | Bullish | |
| $79.54 | $100.47 | $134.54 | +48% | Bullish | |
| $91.82 | $117.55 | $160.24 | +73% | Bullish | |
| $104.18 | $135.00 | $186.93 | +99% | Bullish | |
| $105.30 | $137.99 | $193.80 | +103% | Bullish | |
| $111.97 | $148.28 | $210.94 | +118% | Bullish | |
| $115.67 | $154.71 | $222.72 | +128% | Bullish | |
| $119.32 | $161.09 | $234.49 | +137% | Bullish | |
| $182.63 | $257.17 | $392.29 | +278% | Bullish | |
| $326.00 | $492.34 | $805.03 | +624% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $56.50 | $67.96 | $82.31 | +0.00% |
| August 2026 | $59.61 | $69.79 | $83.48 | +2.69% |
| September 2026 | $58.51 | $68.82 | $82.96 | -1.38% |
| October 2026 | $59.36 | $70.11 | $85.06 | +1.86% |
| November 2026 | $60.28 | $71.45 | $87.17 | +1.92% |
| December 2026 | $59.33 | $70.54 | $86.50 | -1.27% |
Click any year to see its month-by-month UTMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, UTMD is projected to trade between $56.50 and $86.50, averaging $67.96 — a potential gain of 0% from today's $67.96. A consolidation phase looks the most probable path here.
Utah Medical Products, Inc.'s 2027 outlook centres on $75.19, within a $61.58 to $95.99 range. That is up +11% on the projected 2026 average. That marks a +11% change versus current levels. Price action looks broadly range-bound.
By 2028, UTMD could reach as high as $118.57, with a base case around $90.44 and support toward $72.70 — roughly +33% from $67.96. Buyers look set to stay in control over this stretch.
Expect UTMD to range from $79.54 to $134.54 through 2029. The $100.47 average target implies a +48% move from current prices. That is up +11% on the projected 2028 average. Momentum favours further upside here.
The UTMD price prediction for 2030 points to an average of $117.55 (low $91.82, high $160.24) — a potential gain of +73% on today's $67.96. Buyers look set to stay in control over this stretch.
In 2031, UTMD is projected to trade between $104.18 and $186.93, averaging $135.00 — a potential gain of +99% from today's $67.96. That is up +15% on the projected 2030 average. Momentum favours further upside here.
Utah Medical Products, Inc.'s 2032 outlook centres on $137.99, within a $105.30 to $193.80 range. That is up +2% on the projected 2031 average. That marks a +103% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, UTMD could reach as high as $210.94, with a base case around $148.28 and support toward $111.97 — roughly +118% from $67.96. Momentum favours further upside here.
Expect UTMD to range from $115.67 to $222.72 through 2034. The $154.71 average target implies a +128% move from current prices. That is up +4% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The UTMD price prediction for 2035 points to an average of $161.09 (low $119.32, high $234.49) — a potential gain of +137% on today's $67.96. Momentum favours further upside here.
In 2040, UTMD is projected to trade between $182.63 and $392.29, averaging $257.17 — a potential gain of +278% from today's $67.96. That is up +60% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Utah Medical Products, Inc.'s 2050 outlook centres on $492.34, within a $326.00 to $805.03 range. That is up +91% on the projected 2040 average. That marks a +624% change versus current levels. Momentum favours further upside here.
Investing $1,000 in UTMD today (≈ 14.714538 UTMD) could be worth
$7,244.59
+$6,244.59 (+624%) by 2050 · US Dollar
Based on the average projected UTMD price of $492.34 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in UTMDwould be worth at today's price.
$1,000 invested in UTMD on Jul 10, 2025 (≈ 17.479462 UTMD) would be worth
$1,187.9
+$187.9 (+18.8%) today · 1.19× · US Dollar
Based on a UTMD entry price of $57.21 vs. today's $67.96.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $72.78 | $933.77 | -6.6% |
| 1 month ago | $68.6 | $990.67 | -0.9% |
| 3 months ago | $65.9 | $1,031.26 | +3.1% |
| 6 months ago | $59.88 | $1,134.94 | +13.5% |
| 1 year ago | $57.21 | $1,187.9 | +18.8% |
| All time (5.0y) ago | $85.57 | $794.2 | -20.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our UTMD forecast.
Our base-case forecast reaches $140.00 around 2033.
Implied market cap at $140.00: $445.76M
The multi-year forecast shows a clear growth trajectory in average prices: 2026 min $56.50, avg $69.44, max $90.36 (ROI 0), sentiment Neutral; 2027 min $67.79, avg $82.91, max $106.10 (ROI 19.4), sentiment Neutral; 2028 min $79.20, avg $98.65, max $129.58 (ROI 42.1), sentiment Bullish; 2029 min $89.84, avg $113.61, max $152.36 (ROI 63.6), sentiment Bullish; 2030 min $106.69, avg $136.72, max $186.62 (ROI 96.9), sentiment Bullish.
Beyond 2030, the forecast continues to rise: 2031 min $119.83, avg $155.42, max $215.47 (ROI 123.8); 2032 min $122.37, avg $160.51, max $225.66 (ROI 131.2); 2033 min $133.32, avg $176.70, max $251.61 (ROI 154.5); 2034 min $137.21, avg $183.65, max $264.62 (ROI 164.5); 2035 min $146.05, avg $197.33, max $287.48 (ROI 184.2).
Longer-horizon targets remain robust: 2040 min $225.55, avg $317.81, max $485.10 (ROI 357.7), sentiment Bullish; 2050 min $436.72, avg $659.89, max $1,079.49 (ROI 850.3), sentiment Bullish. These figures reflect an evolving positive bias, with increasingly wider price ranges and much higher upside potential over the coming decades. Risks include that these are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $136.72; Min $106.69; Max $186.62; ROI 96.9; sentiment Bullish.
The forecasts show rising averages and sizable long‑term upside (e.g., 2030 Avg $136.72, 2040 Avg $317.81, 2050 Avg $659.89 with ROI 96.9 and 850.3). These are estimates, not guarantees, and should be weighed against risk and individual circumstances.
Yes—the 2030 max forecast is $186.62, with a 2030 min of $106.69 and avg of $136.72.
For 2026, the min is $56.50, the avg is $69.44, and the max is $90.36, with sentiment Neutral.
2040 Avg $317.81; 2050 Avg $659.89; Maxes $485.10 (2040) and $1,079.49 (2050); ROI 357.7 (2040) and 850.3 (2050); sentiment Bullish for the longer horizon.
Utah Medical Products, Inc. Community Discussion
0Share your Utah Medical Products, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.